ATT CEO Highlights BlueCollar Demand as AI Reshapes US Workforce Tulsi Gabbard Resigns as Director of National IntelligenceWhat It Means for National Security and Markets Stocks Edge Lower on Oil Price Volatility and Middle East Peace Deal Uncertainty PMI Data Awaited Microsoft and Anthropic in Advanced Talks for AI Chip Collaboration Following 5 Billion Investment Telecom CEO Warns Europe Risks Connectivity Blackout with Starlinks Satellite Dominance Iran Intensifies Strategic Claims Over Strait of Hormuz with New Military Oversight Map USCB Financial Holdings Inc Q1 2026 Earnings EPS Surpasses Estimates by 548 Amid Steady Performance Kaltura Q1 2026 Earnings EPS Surges Past Estimates Amid Operational Efficiency MNR Q1 2026 Earnings Significant EPS Miss Amid Challenging Commodity Environment NextNRG Inc Q1 2026 Earnings Narrowing Losses Exceed Expectations Amid Strategic Progress BLNK Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline HIMX Q1 2026 Earnings Narrow EPS Beat in a Cautious Semiconductor Landscape Rand Capital Edges Lower A Cautious Move Within Established Boundaries NCS Multistage Holdings NCSM Eases Slightly as Traders Eye Key Support and Resistance Levels OFS Capital Corporation 495 Notes due 2028 OFSSH Hold Steady at 239 as Market Awaits Direction BRC Inc BRCC Declines 257 as Shares Approach Key Support Level NerdWallet NRDS Gains 248 as Digital Personal Finance Platform Shows Resilience Marvell Technology Shares Climb on AI Chip Demand Optimism StoneX Group Q1 2026 Earnings EPS Surges Past Estimates with 365 Surprise Trimble Inc TRMB Declines Nearly 3 Approaching Key Support at 5193 Microbot Medical MBOT Rallies Nearly 6 as Trading Volume Spikes Ready Capital RC Shows Resilience Bounces from Support Eyes Resistance at 192 Golden Entertainment GDEN Holds Steady at 2855 as Support and Resistance Levels Come into Focus Hayward Holdings Inc HAYW Gains Momentum Key Levels and What Lies Ahead Lakeshore Acquisition III Corp Rights LCCCR Holds Steady at 024 Amid Limited Activity Iovance Biotherapeutics IOVA Surges 5 Bulls Test Resistance at 451 TScan Therapeutics TCRX Rallies 39 as Shares Test Key Resistance Levels